Yearly Archives: 2017

Christina Usher Interviewed by the BBC

Christina Usher was interviewed by the BBC for an upcoming special, “The Truth About Carbs”. The interview covered what we currently know about the amylase gene and its impact on metabolism. See Christina’s paper in Nature Genetics on amylase, from her Ph.D. work in the lab.

Fenna Krienen in Science

An article on the Science website describes Fenna’s research to map the brain – first cataloging long-range synaptic connections in the human brain (in Randy Buckner’s lab) and now analyzing the conservation of neuronal types and subtypes across species (in our lab).

Schizophrenia and the Complement Proteins

The work of our Aswin Sekar et al. implicate excessive complement activity in the development of schizophrenia and may help explain the reduced numbers of synapses in the brains of individuals with schizophrenia. For more information, check out: An article in Harvard Magazine, featuring an image of C4 protein at synapses, which was taken by our Heather de Rivera; An article in the New Yorker; An article in the New York Times

Amnon Koren receives the NIH Director’s New Innovator Award

Amnon Koren has won the NIH Director’s New Innovator Award, a grant that funds high-risk, high-reward projects from creative, budding scientists at the beginning of their careers as independent investigators. The New Innovators are considered to be among the best and brightest newcomers to PI-dom and each receive a bio […]

Evan Macosko is among MIT Technology Review’s “35 Innovators Under 35”

Evan Macosko has been named a top inventor in the MIT Technology Review’s “35 Innovators Under 35” for his work on inventing Drop-seq. Evan’s Drop-seq technology, which he developed during his postdoctoral research in the McCarroll lab, makes it possible to analyze gene expression in thousands of individual cells simultaneously. […]

TP53 Mutations in Stem Cells

Articles by Stat News and GEN on our discovery (together with Kevin Eggan’s lab) that pluripotent stem cells routinely acquire dominant-negative mutations in the TP53 gene.  Florian Merkle and Sulagna (Dia) Ghosh led the research team.